Furthermore, this study highlighted the potential of IL-38 inhibition as a co-treatment with chemotherapy, with combined treatment resulting in smaller tumour sizes and increased TIL infiltration compared to chemotherapy alone [96]. The gene discussed is IL1F10; the disease is neoplasm.